609 related articles for article (PubMed ID: 18365395)
1. Urological malignancy as a complication of renal transplantation: a report of twelve clinical cases.
Zhou M; Zhu Y; Wang L; Wang Y; Fu S; Min Z
Clin Transpl; 2006; ():395-8. PubMed ID: 18365395
[TBL] [Abstract][Full Text] [Related]
2. Anticancer effect of sirolimus in renal allograft recipients with de novo malignancies.
Boratyńska M; Watorek E; Smolska D; Patrzałek D; Klinger M
Transplant Proc; 2007 Nov; 39(9):2736-9. PubMed ID: 18021973
[TBL] [Abstract][Full Text] [Related]
3. Transitional cell carcinoma in renal transplant recipients: a single center experience.
Li XB; Xing NZ; Wang Y; Hu XP; Yin H; Zhang XD
Int J Urol; 2008 Jan; 15(1):53-7. PubMed ID: 18184173
[TBL] [Abstract][Full Text] [Related]
4. Therapeutic management of de novo urological malignancy in renal transplant recipients: the experience of the French Department of Urology and Kidney Transplantation from Bordeaux.
Elkentaoui H; Robert G; Pasticier G; Bernhard JC; Couzi L; Merville P; Ravaud A; Ballanger P; Ferrière JM; Wallerand H
Urology; 2010 Jan; 75(1):126-32. PubMed ID: 19864001
[TBL] [Abstract][Full Text] [Related]
5. Chronologically different incidences of post-transplant malignancies in renal transplant recipients: single center experience.
Ju MK; Joo DJ; Kim SJ; Huh KH; Kim MS; Jeon KO; Kim HJ; Kim SI; Kim YS
Transpl Int; 2009 Jun; 22(6):644-53. PubMed ID: 19220824
[TBL] [Abstract][Full Text] [Related]
6. [Clinical character of renal transplant recipients with bilateral native upper urinary transitional cell carcinoma].
Zhang P; Wang Y; Zhang XD; Hu XP; Wang W; Zhang Y; Yin H
Zhonghua Yi Xue Za Zhi; 2009 Feb; 89(4):248-50. PubMed ID: 19552841
[TBL] [Abstract][Full Text] [Related]
7. [De novo urological neoplasms in kidney transplant patients: experience in 1,751 patients].
di Capua Sacoto C; Luján Marco S; Bahilo Mateu P; Budía Alba A; Pontones Moreno JL; Jiménez Cruz JF
Actas Urol Esp; 2010 Jan; 34(1):88-94. PubMed ID: 20223138
[TBL] [Abstract][Full Text] [Related]
8. Hepatocellular carcinoma following renal transplantation: experience in northern Taiwan.
Chiang YJ; Wang HH; Liu KL; Chu SH; Lee WC
Transplant Proc; 2008 Sep; 40(7):2397-9. PubMed ID: 18790246
[TBL] [Abstract][Full Text] [Related]
9. Treatment of oropharyngeal cancer in renal transplant recipients without cessation of immunosuppressive therapy.
Singh SK; Gupta AK; Jha V; Kohli HS; Gupta KL; Minz M; Sakhuja V
Transplant Proc; 2006 Sep; 38(7):2088-9. PubMed ID: 16980008
[TBL] [Abstract][Full Text] [Related]
10. Outcome of Kaposi's sarcoma and graft following discontinuation of immunosuppressive drugs in renal transplant recipients.
Firoozan A; Hosseini Moghaddam SM; Einollahi B; Pour-Reza-Gholi F; Nafar M; Basiri A; Ebrahimi-Rad R
Transplant Proc; 2005 Sep; 37(7):3061-4. PubMed ID: 16213305
[TBL] [Abstract][Full Text] [Related]
11. Post-kidney transplant surgical complications under new immunosuppressive regimens.
Burgos FJ; Pascual J; Quicios C; Marcen R; Fernández A; López Fando L; Ortuño J
Transplant Proc; 2006 Oct; 38(8):2445-7. PubMed ID: 17097962
[TBL] [Abstract][Full Text] [Related]
12. Development of urological cancers in renal transplant recipients: 30-year experience at the Frankfurt Transplant Center.
Tsaur I; Karalis A; Probst M; Blaheta RA; Scheuermann EH; Gossmann J; Kachel HG; Hauser IA; Jonas D; Obermüller N
Cancer Sci; 2010 Nov; 101(11):2430-5. PubMed ID: 20707803
[TBL] [Abstract][Full Text] [Related]
13. [Individual immunosuppressive regime in heart transplantation with high risk].
Wu XJ; Chen LW; Chen DZ; Huang XS; Cao H
Zhonghua Wai Ke Za Zhi; 2008 Jun; 46(11):820-2. PubMed ID: 19035214
[TBL] [Abstract][Full Text] [Related]
14. [Cancer after kidney transplantation and immunosuppression].
Ivanovski N; Popov Z; Kolevski P; Cakalaroski K; Antova Z; Spasovski G; Vlckova-Laskovska M; Zografski G
Ann Urol (Paris); 2000 Oct; 34(5):336-9. PubMed ID: 11144722
[TBL] [Abstract][Full Text] [Related]
15. [Occurrence, types, and therapies of malignant tumors in recipients of renal transplantation].
Liu GH; Li HZ; Wang HJ; Mao QZ; Xia M; Xie Y; Xue C; Wang H; Ji ZG
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2009 Jun; 31(3):288-91. PubMed ID: 19621511
[TBL] [Abstract][Full Text] [Related]
16. De novo malignancies after renal transplantation--a single-center experience in the Balkans.
Popov Z; Ivanovski O; Kolevski P; Stankov O; Petrovski D; Cakalaroski K; Ivanovski N
Transplant Proc; 2007 Oct; 39(8):2589-91. PubMed ID: 17954184
[TBL] [Abstract][Full Text] [Related]
17. Conversion to rapamycin immunosuppression for malignancy after kidney transplantation.
Manuelli M; De Luca L; Iaria G; Tatangelo P; Sforza D; Perrone L; Bellini MI; Angelico R; Anselmo A; Tisone G
Transplant Proc; 2010 May; 42(4):1314-6. PubMed ID: 20534289
[TBL] [Abstract][Full Text] [Related]
18. Comparison of demographic data and immunosupression protocol in patients with and without malignancy after kidney transplantation.
Akbarzadehpasha A; Oliaei F; Asrari MR; Alizadeh-Navaei R
Saudi J Kidney Dis Transpl; 2010 Nov; 21(6):1044-7. PubMed ID: 21060171
[TBL] [Abstract][Full Text] [Related]
19. Hepatocellular carcinoma in renal transplant recipients.
Chuang CH; Chien YS; Cheng YT; Chen YT; Hu TH; Hsieh H
Transplant Proc; 2008 Sep; 40(7):2392-4. PubMed ID: 18790244
[TBL] [Abstract][Full Text] [Related]
20. Conversion to rapamycin immunosuppression for malignancy after kidney transplantation: case reports.
Iaria G; Anselmo A; De Luca L; Manuelli M; Lucchesi C; Tariciotti L; Monaco A; Sforza D; Nigro F; Abruzzese E; Tisone G
Transplant Proc; 2007; 39(6):2036-7. PubMed ID: 17692685
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
